Latest filing published 14 May 2021 for Precision Biosciences INC, €72k.
Filing timeline
BuySaleInsider track record
Matthew R. Kane: trading record in brief
Matthew R. Kane, listed as chief executive, appears in our data through filings on Precision Biosciences Inc shares, published by SEC (Form 4). Over a trading history stretching from 23 September 2019 to 13 May 2021, the count stands at 32 filings.
Sales make up the whole of the open-market record (15 sales, €1.3M). The rest of the record consists of 17 option exercises. Since January 2021: no purchases and 15 sales on the market.
The latest filing, published on 14 May 2021, reports an open-market sale of €72k in Precision Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Matthew R. Kane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,675 shares@ US$8.965.2% of flowCommon StockSEC:0001209191-21-032773:1
- 21,514 shares@ US$0.0450.0% of flowCommon StockSEC:0001209191-21-032773:0
- 9,742 shares@ US$8.575.0% of flowCommon StockSEC:0001209191-21-031670:1
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-031670:2
- 9,746 shares@ US$8.254.8% of flowCommon StockSEC:0001209191-21-031670:3
- 21,514 shares@ US$0.0450.0% of flowCommon StockSEC:0001209191-21-031670:0
- 13,422 shares@ US$1.181.0% of flowCommon StockSEC:0001209191-21-028105:0
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-026663:0
- 9,741 shares@ US$8.675.2% of flowCommon StockSEC:0001209191-21-026663:1
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-026375:2
- 9,737 shares@ US$8.875.3% of flowCommon StockSEC:0001209191-21-026375:3
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-026375:0
- 9,736 shares@ US$9.005.4% of flowCommon StockSEC:0001209191-21-026375:1
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-020823:0
- 9,712 shares@ US$11.366.7% of flowCommon StockSEC:0001209191-21-020823:1
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-020273:0
- 9,710 shares@ US$11.797.0% of flowCommon StockSEC:0001209191-21-020273:1
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-020273:2
- 9,711 shares@ US$11.386.7% of flowCommon StockSEC:0001209191-21-020273:3
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-012745:0
- 9,705 shares@ US$12.237.2% of flowCommon StockSEC:0001209191-21-012745:1
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-011888:0
- 9,697 shares@ US$13.307.7% of flowCommon StockSEC:0001209191-21-011888:1
- 21,514 shares@ US$0.040.1% of flowCommon StockSEC:0001209191-21-011888:2
- 9,705 shares@ US$12.287.2% of flowCommon StockSEC:0001209191-21-011888:3
25 of 32 declarations
